Regeneron
Science That Saves Lives — Accessible to Every Patient It Can Reach
-
WCAG 2.1 AA
Compliance Achieved
-
Branded Site
Pharma Marketing Website
-
Real Users
Tested with Disabled Testers
The Challenge
Regeneron is one of the most scientifically distinguished biotechnology companies in the world, with a portfolio of medicines that have transformed treatment for serious conditions across multiple disease areas.
Regeneron is one of the most scientifically distinguished biotechnology companies in the world, with a portfolio of medicines that have transformed treatment for serious conditions across multiple disease areas. Their branded pharmaceutical marketing websites are a primary information resource for patients, caregivers, and healthcare professionals seeking to understand treatment options — making digital accessibility a direct extension of Regeneron's commitment to patient impact.
A review of one of Regeneron's branded websites against WCAG 2.1 AA standards surfaced real barriers for users relying on assistive technologies — including issues with screen reader navigation, keyboard accessibility, and the usability of dynamic content components that are common in pharmaceutical marketing sites. With ADA Title III litigation in the pharmaceutical sector accelerating, and with the genuine patient equity stakes involved, Regeneron needed a partner equipped to resolve these issues completely.
For a company that prides itself on scientific rigor and evidence-based outcomes, an accessibility program that relied on automated scanning alone — missing the majority of real-world barriers — was not acceptable. Regeneron needed human-led expertise and real-world validation.
The Inclusive Web Solution
Inclusive Web conducted a human-led WCAG 2.1 AA audit of Regeneron's branded pharmaceutical marketing website, bringing the same standard of rigor to accessibility that Regeneron applies to its science. Our team evaluated every critical patient and caregiver flow — from treatment information and mechanism of action content to safety data, patient support resources, and provider tools.
We developed a prioritized remediation roadmap and worked with Regeneron's digital team through every fix — verifying each resolution before sign-off and concluding with real-user testing to confirm the experience works in practice for patients who rely on assistive technologies.
Human-led WCAG 2.1 AA audit of the full branded pharmaceutical marketing website
Patient, caregiver, and HCP journey flows all evaluated — treatment information, MOA content, safety data, and support resources
Accessibility review of dynamic content components common in pharmaceutical marketing — tabbed content, accordions, interactive safety disclosures, and video content
Prioritized remediation roadmap by patient impact and ADA compliance risk
Developer-ready guidance tailored to the site's technical architecture
Fix verification — no issue closed without real-world confirmation it is resolved
Real-user testing with testers who identify as disabled, validating the full site experience using screen readers, keyboard navigation, and voice control
Ongoing monitoring program to maintain compliance through content updates and new campaign launches
Real-User Accessibility Testing — When Health Information Must Be Accessible to All
Inclusive Web validated Regeneron's branded pharmaceutical website with testers who identify as disabled and rely on assistive technologies daily — including screen readers (JAWS, NVDA, VoiceOver), keyboard-only navigation, and voice control. In healthcare, this means ensuring that patients, caregivers, and healthcare professionals who need information about a treatment can access it fully and independently — regardless of ability.
The Result
WCAG 2.1 AA compliance achieved across the Regeneron branded pharmaceutical marketing website
All patient, caregiver, and HCP-facing content and flows made fully accessible to users relying on assistive technologies
Dynamic pharmaceutical content components — including interactive safety disclosures, tabbed content, and video — made accessible
ADA Title III legal exposure substantially reduced
Real-user testing confirmed that patients and caregivers with disabilities can access treatment information with complete independence
Ongoing monitoring in place to maintain compliance as the site evolves with new campaign and regulatory content
"Life-saving treatments only matter if patients can access the information. Regeneron’s digital experience needed to match its scientific standards. Inclusive Web ensured every patient could reach it."
REGENERON – PHARMACEUTICAL ACCESSIBILITY CASE STUDY
Services Delivered
WCAG 2.1 AA Audit (Branded Pharma Website)
Remediation Verification
Multi-Audience Journey Audit (Patient, Caregiver, HCP)
Real-User Usability Testing
Dynamic Content Component Accessibility Review
Ongoing Accessibility Monitoring
Compliance & Regulatory Drivers
Federal obligations and public expectations that made this work essential.
ADA Title III Legal Risk Mitigation
WCAG 2.1 AA Compliance
Patient Equity & Scientific Mission
Pharmaceutical Digital Property Compliance
Does your branded treatment website meet the same standard of rigor as your science?
Inclusive Web helps pharmaceutical and healthcare companies ensure their branded digital properties are accessible to every patient, caregiver, and healthcare professional who depends on them.